These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 6228189)
21. Comparison between antibody-induced modulation of suppressor cells and suppressor cell changes in multiple sclerosis. Antel JP; Oger JJ; Arnason BG Trans Am Neurol Assoc; 1981; 106():233-6. PubMed ID: 6217621 [No Abstract] [Full Text] [Related]
22. Cerebrospinal fluid and peripheral blood lymphocyte subpopulations in multiple sclerosis. Evaluation by means of monoclonal antibodies (a preliminary note). Biglino A; Baggio GF; Gioannini P; Mombelli A Boll Ist Sieroter Milan; 1982; 61(5):432-6. PubMed ID: 6242102 [TBL] [Abstract][Full Text] [Related]
23. The effects of immunomodulation on peripheral T cell subsets. Chatenoud L; Berrih S; Bene MC; Kreis H; Bach JF J Clin Immunol; 1982 Jul; 2(3 Suppl):61S-66S. PubMed ID: 6290529 [TBL] [Abstract][Full Text] [Related]
24. Adhesion molecule expression on cerebrospinal fluid T lymphocytes: evidence for common recruitment mechanisms in multiple sclerosis, aseptic meningitis, and normal controls. Svenningsson A; Hansson GK; Andersen O; Andersson R; Patarroyo M; Stemme S Ann Neurol; 1993 Aug; 34(2):155-61. PubMed ID: 8338339 [TBL] [Abstract][Full Text] [Related]
25. Studies on T cell subsets and functions in leprosy. Bach MA; Chatenoud L; Wallach D; Phan Dinh Tuy F; Cottenot F Clin Exp Immunol; 1981 Jun; 44(3):491-500. PubMed ID: 6459897 [TBL] [Abstract][Full Text] [Related]
26. Low T8 antigen density on lymphocytes in active multiple sclerosis. Reder AT; Antel JP; Oger JJ; McFarland TA; Rosenkoetter M; Arnason BG Ann Neurol; 1984 Aug; 16(2):242-9. PubMed ID: 6236742 [TBL] [Abstract][Full Text] [Related]
27. T lymphocyte redistribution between peripheral blood and cerebrospinal fluid in active multiple sclerosis. Biglino A; Baggio GF; Gioannini P Boll Ist Sieroter Milan; 1984 May; 63(2):150-3. PubMed ID: 6235822 [TBL] [Abstract][Full Text] [Related]
28. Mitogen-induced plasma cell differentiation in patients with multiple sclerosis. Levitt D; Griffin NB; Egan ML J Immunol; 1980 May; 124(5):2117-21. PubMed ID: 6965966 [TBL] [Abstract][Full Text] [Related]
29. Interferon beta augments suppressor cell function in multiple sclerosis. Noronha A; Toscas A; Jensen MA Ann Neurol; 1990 Feb; 27(2):207-10. PubMed ID: 2138445 [TBL] [Abstract][Full Text] [Related]
31. T-lymphocyte subpopulations in rheumatoid arthritis. II. Definition by monoclonal antibodies. Pfreundschuh M; Michel H; Parino G; Gram N; Stock C; Gause A; Hunstein W Z Rheumatol; 1981; 40(6):245-9. PubMed ID: 6460396 [TBL] [Abstract][Full Text] [Related]
32. Mitoxantrone does not restore the impaired suppressive function of natural regulatory T cells in patients suffering from multiple sclerosis. A longitudinal ex vivo and in vitro study. Putzki N; Kumar M; Kreuzfelder E; Grosse-Wilde H; Diener HC; Limmroth V Eur Neurol; 2009; 61(1):27-32. PubMed ID: 18948697 [TBL] [Abstract][Full Text] [Related]
33. Lymphocytotoxic antibody in multiple sclerosis: activity against T cell subsets and correlation with disease activity. Scott CF; Spitler LE Clin Exp Immunol; 1983 Jul; 53(1):133-9. PubMed ID: 6223730 [TBL] [Abstract][Full Text] [Related]
34. Interferon-gamma secretion by peripheral blood T-cell subsets in multiple sclerosis: correlation with disease phase and interferon-beta therapy. Becher B; Giacomini PS; Pelletier D; McCrea E; Prat A; Antel JP Ann Neurol; 1999 Feb; 45(2):247-50. PubMed ID: 9989628 [TBL] [Abstract][Full Text] [Related]
35. [Two-color flow cytometry analysis of lymphocyte subsets in patients with acute myocardial infarction and post-myocardial infarction syndrome]. Tsuchihashi M; Sakaguchi Y; Nakamura M; Sutani T; Tsuruta S; Kato S; Uemura S; Nishida Y; Hashimoto T; Kagoshima T J Cardiol; 1995 Aug; 26(2):69-79. PubMed ID: 7674146 [TBL] [Abstract][Full Text] [Related]
36. Depressed effector activity of OKT4+ and OKT8+ T cell subsets in lectin-dependent cell-mediated cytotoxicity to HEP-2 cells in patients with systemic lupus erythematosus. Perl A; Gonzalez-Cabello R; Gergely P J Clin Lab Immunol; 1984 Oct; 15(2):95-100. PubMed ID: 6240539 [TBL] [Abstract][Full Text] [Related]
37. [Mechanism of formation of active T-rosette forming cells in multiple sclerosis patients]. Matveeva TV; D'iakonova IN; Shaĭdullina FS Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(2):21-5. PubMed ID: 6972132 [TBL] [Abstract][Full Text] [Related]
38. Immunoregulatory abnormalities in chronic lymphocytic leukemia. I. Correlations of immunoregulatory subpopulations with stage of disease. Keller RH; Blake DG; Lyman S; Siebenlist R J Clin Lab Immunol; 1981 Nov; 6(3):201-9. PubMed ID: 6461766 [TBL] [Abstract][Full Text] [Related]
39. [Peripheral blood gamma delta T cells in multiple sclerosis]. Ejima M; Ota K; Tanaka H; Maruyama S Rinsho Shinkeigaku; 1993 Nov; 33(11):1131-4. PubMed ID: 8124869 [TBL] [Abstract][Full Text] [Related]
40. The influence of chrysotherapy on T-lymphocyte subpopulations in rheumatoid arthritis. Pfreundschuh M; Parino G; Gram N; Bröker A; Gause A; Hunstein W Z Rheumatol; 1983; 42(6):328-31. PubMed ID: 6229937 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]